Monoclonal Antibody Treatment Reduced Deaths in Hospitalized COVID Patients
A monoclonal antibody treatment taken by patients hospitalized with COVID-19 did not improve recovery time but did reduce deaths, according to a study published July 8 in The Lancet Respiratory Medicine.
Meet Gerald Grant, MD, Chair of the Duke Department of Neurosurgery
A rich background -- which included time in the US Air Force and Iraq and as an endowed professor, associated dean, and chief of pediatric neurosurgery at Stanford University-- contributed to the making of Grant into an outstanding leader poised to take Duke Neurosurgery to new and exciting directions.
Real-time Imaging Helps Women Avoid Repeat Surgery After Lumpectomy
A Duke University School of Medicine study shows the potential of new imaging technology to change the landscape of breast cancer surgery.
Postdoctoral Researchers Named MOSAIC Scholars
The MOSAIC program is part of the National Institutes of Health’s efforts to enhance diversity within the academic biomedical research workforce and is designed to facilitate the transition of promising postdoctoral researchers from diverse backgrounds into independent, tenure-track or equivalent research-intensive faculty positions.
Division of Emergency Medicine Elevated to Department Status; Gerardo Named Interim Chair
The Division of Emergency Medicine within the Department of Surgery in the Duke University School of Medicine will be elevated to department status, effective July 1, 2022.
Barbara Sheline Starts a New Chapter After 32 Years at Duke
Barbara Sheline, MD, MPH, who has directed the Primary Care Leadership Track (PCLT) program in the Duke University School of Medicine since its establishment in 2011, retired on June 30, 2022.
Role Identified for Key Gene in Developmental Disability Syndrome
A single gene that was previously found to be the driving force in a rare syndrome linked to epilepsy, autism and developmental disability has been identified as a linchpin in the formation of healthy neurons.
Fish Oil Appears to Ease Post-Operative Delirium in Pre-Clinical Studies
Fish oil triglycerides appear to be effective at reducing instances of inflammation in the brain and preventing post-surgical delirium in mice and tissue engineered human models, according to Duke Health and Duke Biomedical Engineering researchers.
CTSI Makes MURDOCK Biorepository Samples, Data Available to Researchers
The Duke Clinical and Translational Science Institute (CTSI) has announced a new opportunity for Duke investigators to obtain biospecimens from the MURDOCK Study for research. The MURDOCK study is a landmark longitudinal cohort of more than 12,000 diverse participants linked to clinical data and up to 14 years of outcomes data.
Congratulations to the 2022 LEADER Alumni!
The Leadership Development for Researchers (LEADER) Program is designed for junior faculty who are leading a research group and driving their own research agenda.